Darryl Ballard

496 total citations
15 papers, 280 citations indexed

About

Darryl Ballard is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Darryl Ballard has authored 15 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Physiology. Recurrent topics in Darryl Ballard's work include Cancer Genomics and Diagnostics (3 papers), Immunotoxicology and immune responses (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Darryl Ballard is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Immunotoxicology and immune responses (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Darryl Ballard collaborates with scholars based in United States. Darryl Ballard's co-authors include Yunfei Chen, Elizabeth J. Galbreath, Michael Y. Sherman, Philip W. Iversen, Beverly A. Teicher, Mark D. Williams, Suzane L. Um, William L. Macias, S. Betty Yan and George E. Sandusky and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Darryl Ballard

14 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darryl Ballard United States 6 136 51 49 48 35 15 280
Hao Ding China 12 157 1.2× 86 1.7× 29 0.6× 56 1.2× 18 0.5× 33 372
O. A. Antonova Russia 10 107 0.8× 32 0.6× 26 0.5× 29 0.6× 18 0.5× 30 297
Shruti Daga United Kingdom 10 98 0.7× 41 0.8× 47 1.0× 67 1.4× 12 0.3× 16 295
Hakim Ouled‐Haddou France 13 116 0.9× 51 1.0× 23 0.5× 93 1.9× 75 2.1× 30 357
Kanyalakshmi Ayyanar United States 7 214 1.6× 83 1.6× 16 0.3× 18 0.4× 30 0.9× 10 351
Liana Nikolaenko United States 12 83 0.6× 156 3.1× 80 1.6× 31 0.6× 33 0.9× 41 372
Jordi Vilardell Spain 12 229 1.7× 93 1.8× 27 0.6× 19 0.4× 27 0.8× 17 445
Iván Parra‐Izquierdo United States 11 90 0.7× 25 0.5× 64 1.3× 17 0.4× 27 0.8× 18 335
Daria V. Serebryanaya Russia 8 141 1.0× 55 1.1× 22 0.4× 26 0.5× 9 0.3× 19 501
Cuiping Zhang China 11 184 1.4× 63 1.2× 45 0.9× 13 0.3× 21 0.6× 43 371

Countries citing papers authored by Darryl Ballard

Since Specialization
Citations

This map shows the geographic impact of Darryl Ballard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl Ballard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl Ballard more than expected).

Fields of papers citing papers by Darryl Ballard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl Ballard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl Ballard. The network helps show where Darryl Ballard may publish in the future.

Co-authorship network of co-authors of Darryl Ballard

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl Ballard. A scholar is included among the top collaborators of Darryl Ballard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl Ballard. Darryl Ballard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Schroeder, Matthew, et al.. (2021). Effects of 0.5% and 2.0% Sodium Lauryl Sulfate in Male CD-1 Mice From a 3-Month Oral Gavage Toxicity Study. Toxicologic Pathology. 49(5). 1100–1108. 1 indexed citations
4.
Smith, Rosamund C., Martin S. Cramer, Pamela J. Mitchell, et al.. (2020). Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength. PLoS ONE. 15(4). e0230818–e0230818. 32 indexed citations
5.
Smith, Rosamund C., Martin S. Cramer, Pamela J. Mitchell, et al.. (2015). Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle Wasting. Molecular Cancer Therapeutics. 14(7). 1661–1670. 30 indexed citations
6.
Jordan, William H., et al.. (2014). Initial Biological Qualification of SBDP-145 as a Biomarker of Compound-Induced Neurodegeneration in the Rat. Toxicological Sciences. 141(2). 398–408. 5 indexed citations
7.
Yan, S. Betty, Suzane L. Um, Victoria L. Peek, et al.. (2014). Abstract 4403: Preclinical evaluation of LY2801653, an orally bioavailable small molecule oncokinase inhibitor, in cholangiocarcinoma models. Cancer Research. 74(19_Supplement). 4403–4403. 1 indexed citations
8.
Zeng, Wei, Victoria L. Peek, Jonathan W. Tetreault, et al.. (2013). Abstract 5465: LY2875358, a bivalent MET antibody with anti-tumor activity through blocking HGF as well as inducing degradation of MET, differentiates from a one-armed 5D5 MET antibody.. Cancer Research. 73(8_Supplement). 5465–5465. 3 indexed citations
9.
Thobe, Megan N., Suzane L. Um, Victoria L. Peek, et al.. (2012). Abstract 2087: Detection of KRAS mutations in circulating tumor cells (CTCs) and in formalin-fixed, paraffin-embedded (FFPE) tissue using castPCR method. Cancer Research. 72(8_Supplement). 2087–2087. 1 indexed citations
10.
Meier, Timothy I., Mark Uhlik, Sudhakar Chintharlapalli, et al.. (2011). Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization. Molecular Cancer Therapeutics. 10(11). 2168–2178. 31 indexed citations
11.
Peek, Victoria L., Suzane L. Um, S. Betty Yan, et al.. (2011). Abstract A49: Circulating tumor cell (CTC) assay development for detection of H2AX as a clinical pharmacodynamic (PD) marker for Chk1 kinase inhibitors.. Molecular Cancer Therapeutics. 10(11_Supplement). A49–A49. 1 indexed citations
12.
Holzer, Timothy R., Kathleen M. Heinz-Taheny, Darryl Ballard, et al.. (2010). Abstract B31: Potential for patient tailoring for prodrug of gemcitabine (LY2334737) by assessment carboxylesterase II expression in solid tumor biopsies. Clinical Cancer Research. 16(14_Supplement). B31–B31. 2 indexed citations
13.
Pratt, Susan E., et al.. (2010). Abstract B36: Identification of carboxylesterase 2 as a hydrolase that cleaves the prodrug of gemcitabine LY2334737. Clinical Cancer Research. 16(14_Supplement). B36–B36. 1 indexed citations
14.
Macias, William L., S. Betty Yan, Mark D. Williams, et al.. (2005). New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).. Critical Care. 9(Suppl 4). S38–S38. 69 indexed citations
15.
Sherman, Michael Y., Elizabeth J. Galbreath, Darryl Ballard, et al.. (2004). LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice. Cancer Chemotherapy and Pharmacology. 53(2). 133–140. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao Ding Breakdown of academic impact, for papers by O. A. Antonova Breakdown of academic impact, for papers by Shruti Daga Breakdown of academic impact, for papers by Hakim Ouled‐Haddou Breakdown of academic impact, for papers by Kanyalakshmi Ayyanar Breakdown of academic impact, for papers by Liana Nikolaenko Breakdown of academic impact, for papers by Jordi Vilardell Breakdown of academic impact, for papers by Iván Parra‐Izquierdo Breakdown of academic impact, for papers by Daria V. Serebryanaya Breakdown of academic impact, for papers by Cuiping Zhang
Rankless by CCL
2026